- 4009 Hackney Springs Ln, Sachse, TX 75048
Lab Billing Services in Nevada
TransLabs masters Nevada’s lab billing complexities so you don’t have to. With a 98% clean claim rate and 99% client retention, laboratories that partner with us experience immediate revenue transformation.
Trusted by hospital outreach programs, independent reference labs, and specialty testing facilities across all laboratory disciplines in Nevada.
Nevada’s laboratory billing landscape presents obstacles that drain your resources, frustrate your staff, and leave significant revenue on the table. Here’s what’s costing you:
Nevada Medicaid operates through three MCOs, Molina, Anthem, and Health Plan of Nevada, each with different LCD requirements, authorization protocols, and claim portals. A panel approved by one MCO gets denied by another for identical diagnosis codes.
Nevada’s tourism industry and transient workforce create eligibility verification nightmares. Patients present with out-of-state insurance, expired coverage, or secondary payers. Without real-time verification, labs perform $3,000+ panels only to discover terminated coverage.
Nevada MCOs require prior authorization for genetic, molecular, immunology, and toxicology testing. Approvals average 10-18 days, aging specimens and frustrating physicians. A missed authorization triggers denials taking 45-60 days to appeal, so most labs simply write them off.
Nevada’s large Medicare population demands strict ABN compliance. Missing or improperly executed ABNs trigger automatic write-offs, and one audit finding can spark lookback reviews costing $40,000+ in refunds. With Medicare Advantage, ABN compliance is non-negotiable.
Managing 120+ commercial payers including BCBS Nevada, UnitedHealthcare, Aetna, Cigna, and MA plans means navigating LCDs, frequency limitations, and medical necessity criteria. Billing staff lose 25-35 hours weekly researching policies instead of collecting revenue.
Nevada’s population growth has driven genetic testing utilization, but payers aggressively challenge medical necessity. BRCA, pharmacogenomics, NGS oncology, and hereditary cancer panels face denial rates exceeding 32%, requiring extensive documentation.
We’ll review 50 of your recent Nevada Medicaid MCO claims and identify every LCD violation costing you money.
Statistics show that Nevada laboratories lose between $110,000 and $275,000 annually to billing inefficiencies. TransLabs eliminates your hidden profit drains. Our laboratory-exclusive expertise, Nevada-focused regulatory knowledge, and relentless attention to detail transform your revenue cycle from a constant headache into a reliable revenue generator.
Industry data shows that outsourcing lab billing can save facilities $70,000-$160,000 annually by reducing claim denials, accelerating payments, and eliminating the overhead costs of in-house billing staff. Our clients typically see these results:
From commercial insurers to Medicare and Medicaid, our specialists have the lab-exclusive billing expertise to get your claims paid across every network, every time.
TransLabs provides expert RCM services to clinical laboratories in all 50 states, delivering the same exceptional results whether you’re a community hospital lab or a large reference facility. We bring specialized lab billing expertise to facilities nationwide, combining remote efficiency with hands-on partnership.
TransLabs connects effortlessly with major Nevada lab systems. Our cloud RCM syncs in real time, removes duplicate entries, submits claims, and posts payments with no workflow disruption.
Stop struggling with billing obstacles and start collecting what you’ve earned. TransLabs masters Nevada’s regulations, MCO requirements, and payer-specific policies that make or break your revenue cycle.
Most labs lose 18-25% of collectible revenue to billing errors they never see. Our free audit uncovers denied molecular claims, MCO policy violations, underpayments, and improper modifier usage. No commitment, no catch. Just a clear picture of what's costing you and how to fix it.
A $4,200 NGS panel ordered, then the patient's insurance lapsed or switched MCOs without notice. We verify every patient's coverage, benefits, MCO affiliation, and authorization requirements before testing begins. Real-time checks across 120+ Nevada payers, accurate medical necessity validation, zero surprise denials.
CLIA approved but still waiting on payer enrollment? Medicare takes 90-120 days, Nevada Medicaid MCOs another 45-120 days, commercial payers up to 180 days. We handle Medicare enrollment, NPI registration, CLIA updates, MCO applications, and network agreements so you start billing in-network months sooner.
Your lab staff should be focused on testing, not chasing claims. We handle every step of the billing process including claims submission, payment posting, denial management, and patient statements so nothing falls through the cracks. Our team knows Nevada payer rules, MCO requirements, and lab-specific coding.
From eligibility checks to final payment, we own your entire revenue cycle so nothing slips through the cracks. Every claim is scrubbed, submitted, and tracked across Nevada's complex payer landscape. Every denial is challenged with documented evidence. All underpayments are rectified.
Nevada MCOs require pre-authorization for genetic testing, molecular diagnostics, and specialty panels. Our specialists handle all three MCO submission portals, peer-to-peer reviews, medical necessity documentation, and appeals. Average turnaround: 3.5 days versus the industry standard of 12-15 days.
Denials aren't write-offs; they're revenue waiting to be recovered. Our certified coders and healthcare attorneys appeal denials with an 87% overturn rate, targeting LCD violations, MCO conflicts, bundling errors, and improper downgrades. Every denied claim reviewed, every recoverable dollar fought for.
Medicare's Advance Beneficiary Notice requirements are non-negotiable in Nevada. We ensure proper ABN execution for every non-covered test, maintain compliant documentation, and protect you from audit exposure. Our ABN compliance program holds a 100% audit success rate which is a benchmark for Nevada labs.
Our labs billing services adhere strictly to CMS Laws and HIPAA guidelines
Expert knowledge of all three Nevada Medicaid managed care organizations
CPC, CPB, and laboratory-specific certifications
Medicare and commercial payer enrollment in 45-90 days
Epic, Cerner, Sunquest, SOFT, and custom systems
Clinical, anatomic, molecular, toxicology, and reference labs
Percentage-based or per-claim models, no hidden fees
TransLabs specializes exclusively in Nevada laboratory facilities, giving us unmatched expertise in Nevada Medicaid MCO requirements, BCBS Nevada policies, Medicare MAC J15 requirements, and Nevada-specific payer regulations. Our 96% first-pass clean claim rate and 93% client retention rate reflect our commitment to excellence.
Nevada’s statute of limitations for medical billing is generally four years from the date of service. However, insurance companies have much shorter filing deadlines—typically 90 to 180 days for commercial payers, 365 days for Medicare, and 6-12 months for Nevada Medicaid MCOs. Missing these deadlines forfeits your right to payment, which is why timely claim submission is critical.
The top five denial reasons are:
Yes, all three Nevada Medicaid MCOs (Molina Healthcare, Anthem Blue Cross Blue Shield, and Health Plan of Nevada) require prior authorization for molecular diagnostics, genetic testing, most tests over $500, and specialty immunology panels. Authorization requirements and processes vary by MCO. The authorization process typically takes 7-18 days depending on the MCO, complexity, and medical necessity documentation. TransLabs manages all three MCO portals to ensure approvals are secured before testing begins.
A Local Coverage Determination (LCD) is a Medicare policy that defines which tests are covered, which ICD-10 codes support medical necessity, and testing frequency limitations. Nevada falls under Medicare MAC Jurisdiction 15 (Noridian), which has strict LCDs for molecular and genetic testing. Billing a test with a non-covered diagnosis code results in automatic denial and potential audit exposure.
We pre-verify medical necessity before testing, submit prior authorizations with comprehensive documentation to the appropriate Nevada Medicaid MCO or commercial payer, use LCD-compliant diagnosis coding, attach required medical records, and proactively communicate with payers to prevent denials. For denied claims, we submit detailed appeals with peer-reviewed literature and clinical guidelines. Our molecular/genetic testing claim acceptance rate is 93%.
